Showing results (361-370 of 1,345) with videos related to
Sort By:
Pageof 135
Vascular Medicine (London, England)|August 5, 2006
Ultrasound-detected carotid plaque as a predictor of cardiovascular eventsRachael A Wyman, Maureen E Mays, Patrick E McBride, et al.Vascular Medicine (London, England)|July 10, 2007
Reproducibility and reliability of the ankle-brachial index as assessed by vascular experts, family physicians and nursesTim Holland-Letz, Heinz G Endres, Stefanie Biedermann, et al.Vascular Medicine (London, England)|July 10, 2007
Clinical evidence for anti-inflammatory effects of antiplatelet therapy in patients with atherothrombotic diseaseSteven R Steinhubl, Juan J Badimon, Deepak L Bhatt, et al.Vascular Medicine (London, England)|July 10, 2007
Skin tissue cholesterol is not related to vascular occlusive diseaseMarkus Reiter, Susan Wirth, Ali Pourazim, et al.Vascular Medicine (London, England)|April 25, 2007
Prevalence of erectile dysfunction in vascular surgery patientsJuergen Falkensammer, Albert G Hakaim, Claudia E Falkensammer, et al.Vascular Medicine (London, England)|April 25, 2007
Angiotensin II promotes the inflammatory response to CD40 ligation via TRAF-2Johannes Ruef, Michael Browatzki, Caroline A H Pfeiffer, et al.Vascular Medicine (London, England)|May 14, 2021
Effects of intermittent negative pressure treatment on circulating vascular biomarkers in patients with intermittent claudicationHenrik Hoel, Erik Mulder Pettersen, Lars Øivind Høiseth, et al.Vascular Medicine (London, England)|January 1, 1996
Claudication as an 'orphan disease': rationale and goals of drug therapy for peripheral arterial diseaseA T HirschVascular Medicine (London, England)|January 1, 1996
Experimental models of chronic lower extremity arterial occlusive disease: lessons for drug developmentC D NicholsonVascular Medicine (London, England)|January 1, 1996
Skeletal muscle metabolism as a target for drug therapy in peripheral arterial diseaseE P BrassPageof 135